Evidence map›Paper›PMID 30397607›Full record

ArticleWorld journal of clinical cases2018

CYP2C19 polymorphism has no influence on rabeprazole-based hybrid therapy for

Tsung-Jung Lin, Hsi-Chang Lee, Chih-Lin Lin, Chung-Kwe Wang, Kuan-Yang Chen, Deng-Chyang Wu

Open access · diamondAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in World journal of clinical cases, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.9field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 7 citations in OpenAlex.

  1. Frontiers in pharmacology · 2024
    Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Tsung-Jung LinDepartment of Health care and Social Work, Taipei University of Marine Technology, New Taipei 25172, Taiwan.
Hsi-Chang LeeDepartment of Gastroenterology, Taipei City Hospital, Taipei 10629, Taiwan.
Chih-Lin LinDepartment of Gastroenterology, Taipei City Hospital, Taipei 10629, Taiwan.
Chung-Kwe WangDepartment of Gastroenterology, Taipei City Hospital, Taipei 10629, Taiwan.
Kuan-Yang ChenDepartment of Gastroenterology, Taipei City Hospital, Taipei 10629, Taiwan.
Deng-Chyang WuDivision of Gastroenterology, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung 80708, Taiwan.
Kaohsiung Medical University · TW

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

aimTo evaluate the impact of cytochrome P450 2C19 (CYP2C19) and interleukin-1β (IL-1β) polymorphisms on the efficacy of

methodsA total of 88

resultsThe total eradication rate of

conclusionThe CYP2C19 and IL-1β polymorphisms are not significantly independent factors of

Indexed as

Cytochrome P450 2C19Helicobacter pyloriHybrid therapyInterleukin-1βRabeprazole

Identifiers

PMID30397607
PMCPMC6212610
OpenAlexW2898316828

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.